Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,25489,896,1.08 [0.93-1.25],0.300535588728909
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25524,145,1.01 [0.70-1.44],0.9774193230755038
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27103,156,1.30 [0.92-1.84],0.1356585645117111
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20259,501,1.06 [0.87-1.29],0.5532570254150551
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27040,93,1.48 [0.96-2.30],0.0777955368638648
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26320,79,1.22 [0.75-1.98],0.4221324015979564
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28078,92,1.47 [0.94-2.28],0.0876083458777717
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28099,64,1.43 [0.85-2.41],0.1795094360886702
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25758,45,1.31 [0.70-2.46],0.3997347404182967
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27556,109,1.48 [0.99-2.21],0.0585116944675977
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27515,68,1.22 [0.73-2.04],0.4465431538252288
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28139,67,0.64 [0.37-1.10],0.1076164162150472
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28095,95,1.20 [0.77-1.88],0.42515666002276
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28086,86,1.11 [0.69-1.78],0.6688827451329398
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Mycoses,27905,45,1.43 [0.77-2.66],0.2609331308643331
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27266,389,1.04 [0.83-1.30],0.7337012758858014
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27021,144,0.90 [0.62-1.30],0.572894540575321
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27126,249,1.12 [0.85-1.47],0.4139439890358456
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",24413,30,0.41 [0.19-0.89],0.0244108780832026
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24432,49,0.76 [0.40-1.44],0.3970500753871646
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24510,127,1.52 [1.04-2.24],0.0318466642437881
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24515,132,1.50 [1.03-2.19],0.0355449764163998
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",13732,296,1.57 [1.22-2.03],0.0005420387481674
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",10975,28,0.84 [0.37-1.95],0.6909311411260107
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24430,47,1.48 [0.79-2.75],0.2215668093186146
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,25976,820,1.51 [1.30-1.75],1.098249079503215e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27061,197,0.85 [0.62-1.16],0.3051675869721153
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27714,80,0.78 [0.48-1.26],0.305543602676079
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28214,71,0.83 [0.50-1.39],0.4784176636919274
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Rectum,27973,47,1.07 [0.57-1.99],0.8348677082218339
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28221,40,1.13 [0.57-2.23],0.725639414511706
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Stomach,28262,33,0.89 [0.42-1.90],0.7646576187969659
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm,27954,296,0.95 [0.74-1.23],0.7194750399253891
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28192,116,0.87 [0.58-1.31],0.5097795043521554
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28195,95,0.98 [0.63-1.52],0.9380494026291424
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28158,47,1.00 [0.53-1.88],0.9943718252806968
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma, any site",28160,47,1.00 [0.53-1.88],0.9946995721860856
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi,28058,250,0.94 [0.71-1.24],0.6532679327461737
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,28221,110,1.15 [0.76-1.76],0.5087437241681558
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Other benign neoplasms of skin,28130,191,1.02 [0.75-1.40],0.878459011433222
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of breast,15599,93,1.30 [0.83-2.05],0.2519247983041849
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Leiomyoma of uterus,15240,692,0.92 [0.77-1.08],0.3023441012124337
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27223,198,1.81 [1.34-2.44],0.000115972974267
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27103,353,1.59 [1.26-1.99],7.16348973103736e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27103,353,1.59 [1.26-1.99],7.16348973103736e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),25889,364,1.39 [1.11-1.75],0.0041424013234889
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27778,80,1.49 [0.92-2.40],0.1028556838467861
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27991,107,1.76 [1.17-2.66],0.006471227597127
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,24777,704,1.03 [0.87-1.22],0.7124384940658635
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26934,445,1.22 [0.99-1.50],0.0559164822195295
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,26429,116,0.97 [0.65-1.45],0.8884605375341746
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27492,54,1.12 [0.63-2.01],0.6965478663711462
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26414,101,1.00 [0.65-1.54],0.9849124634443815
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26651,338,0.98 [0.78-1.25],0.8905476943557027
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26643,330,0.97 [0.76-1.23],0.7971946388530177
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,26297,184,0.97 [0.68-1.38],0.8718361880014787
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",26301,181,0.96 [0.67-1.37],0.824583000216983
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24612,539,1.05 [0.87-1.27],0.6379968163009023
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24147,74,1.12 [0.68-1.85],0.6491134157747236
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,24567,494,1.06 [0.87-1.29],0.5835228101290998
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24117,44,0.59 [0.31-1.13],0.1103722021053923
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24151,78,1.09 [0.67-1.79],0.7297607450068901
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Any mental disorder,24512,768,1.04 [0.88-1.22],0.6458971549435315
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24039,295,0.66 [0.51-0.85],0.0016355313993348
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27814,227,0.64 [0.48-0.86],0.002690463018767
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27886,163,0.62 [0.44-0.87],0.0054484875414985
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26252,83,0.85 [0.52-1.39],0.5156257048941133
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",28142,83,0.84 [0.52-1.35],0.4680361399942998
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",23827,83,0.85 [0.52-1.38],0.5072145427796668
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Alcohol dependence,26267,98,0.64 [0.41-1.00],0.0492321833722993
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Smoking dependency,26231,68,0.66 [0.39-1.11],0.1195825514205347
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23818,74,0.73 [0.44-1.21],0.2203927873594405
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24137,393,1.32 [1.06-1.64],0.0140926475830083
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Depression,26513,340,1.37 [1.09-1.73],0.0080172719601246
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Depression or dysthymia,23982,298,1.56 [1.21-2.00],0.0005243322725863
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",23887,143,1.06 [0.74-1.53],0.7477379327778545
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Other anxiety disorders,26738,69,1.16 [0.70-1.94],0.5644837473923854
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Neurological diseases,25116,1450,1.05 [0.94-1.19],0.383169871556562
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23429,161,1.21 [0.85-1.72],0.2833761679531761
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28059,131,1.39 [0.95-2.03],0.0941065587152394
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26895,492,0.98 [0.81-1.20],0.8674598322204669
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Epilepsy,26569,166,0.76 [0.54-1.07],0.1142046570541229
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Migraine,26506,103,1.75 [1.15-2.67],0.0090237626241126
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27885,93,1.88 [1.21-2.92],0.0046468610021649
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27762,40,1.15 [0.58-2.27],0.68722428789599
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other sleep disorders,26578,175,0.79 [0.57-1.10],0.1662124690269756
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Sleep apnoea,27641,137,0.71 [0.49-1.03],0.0685158270636144
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27117,616,1.08 [0.91-1.29],0.3721036433849614
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26638,137,0.94 [0.64-1.37],0.7492599741384445
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26832,331,1.08 [0.85-1.37],0.5330410540762707
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28036,84,0.67 [0.42-1.07],0.0905501770613075
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Hemiplegia,28007,55,0.74 [0.42-1.31],0.3015406414891248
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other neurological diseases,27822,126,1.30 [0.88-1.90],0.1853131959682769
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27786,314,1.23 [0.97-1.57],0.0933959256916013
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27643,171,1.34 [0.97-1.86],0.0762005818837388
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27563,91,1.08 [0.68-1.69],0.755264885477329
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27577,105,1.28 [0.84-1.94],0.2440436471997732
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27522,50,1.09 [0.59-1.99],0.787490486018516
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,26529,65,1.05 [0.62-1.77],0.8631010965481463
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26653,189,1.16 [0.85-1.58],0.3401980343927989
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27635,131,0.87 [0.60-1.27],0.4722970079527112
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28003,24,0.93 [0.39-2.22],0.8714450935366131
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1771,24,1.14 [0.49-2.64],0.765435602385374
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",26256,24,0.91 [0.38-2.19],0.8373479378931077
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27876,50,1.01 [0.55-1.84],0.975744036737922
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27855,29,1.69 [0.79-3.63],0.177513084194183
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27789,96,0.74 [0.47-1.16],0.1856995196065666
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27837,99,1.29 [0.84-1.98],0.2407981855261997
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,28135,120,0.95 [0.64-1.41],0.8141874443240316
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,27735,88,1.31 [0.83-2.08],0.2505058712388135
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22107,1977,1.03 [0.93-1.14],0.5990459175819725
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27930,40,1.13 [0.57-2.21],0.7309821178341498
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23180,1320,1.09 [0.96-1.24],0.1961844163603034
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertension,23204,1344,1.13 [1.00-1.28],0.0580922396676699
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21910,50,6.49 [3.94-10.69],2.088413580756409e-13
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26725,570,1.14 [0.95-1.36],0.1697065695280476
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Angina pectoris,26507,352,1.25 [0.99-1.57],0.0610299533851401
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27538,141,1.12 [0.79-1.60],0.5247125508794646
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27661,264,1.11 [0.85-1.44],0.4480941395925683
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28154,60,1.41 [0.82-2.42],0.2186609023454647
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26316,161,1.18 [0.84-1.65],0.3391543407599467
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26566,422,1.18 [0.96-1.46],0.1151639262665174
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27739,81,1.99 [1.26-3.16],0.0033560399432583
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27729,178,1.60 [1.17-2.19],0.0035896424047202
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27721,63,0.49 [0.28-0.85],0.0104554129545864
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27722,64,0.48 [0.28-0.83],0.0088714655213961
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21920,60,0.44 [0.25-0.78],0.004834775008306
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25594,46,0.58 [0.30-1.12],0.1027393570879816
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Conduction disorders,25623,75,0.96 [0.58-1.59],0.8766769736907534
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19302,95,0.90 [0.57-1.43],0.6627202801762209
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,19397,190,1.07 [0.78-1.48],0.6596899760595898
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other arrhythmias,25589,41,1.34 [0.69-2.61],0.3905561819307868
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25610,62,0.83 [0.47-1.44],0.4981756996289048
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27749,123,1.08 [0.74-1.59],0.6839750422235392
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27714,116,0.87 [0.58-1.30],0.4990687983906502
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27748,86,1.02 [0.65-1.62],0.9277507235821714
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27797,75,0.93 [0.57-1.52],0.765721224084803
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27514,51,0.99 [0.54-1.81],0.9782848126218016
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27548,85,1.70 [1.08-2.68],0.0220875685727493
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27007,118,1.50 [1.02-2.22],0.0391220818271546
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26986,97,1.92 [1.26-2.92],0.0022194377514826
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28091,92,2.13 [1.40-3.26],0.0004634845032486
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Varicose veins,27332,443,1.02 [0.82-1.26],0.8621160120855837
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypotension,27511,56,1.24 [0.70-2.19],0.4620366831334034
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,23921,1968,0.89 [0.80-0.98],0.0244927436454145
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28032,140,1.10 [0.76-1.58],0.6105749367887243
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27040,188,0.72 [0.52-0.99],0.04254106224962
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27011,159,0.82 [0.58-1.16],0.2687154317266393
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27647,213,0.54 [0.40-0.73],5.4694075804654886e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27645,211,0.54 [0.40-0.73],5.793184864508238e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27362,676,1.11 [0.94-1.32],0.2196760940970467
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic sinusitis,26783,97,0.98 [0.63-1.53],0.9360372426666784
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Nasal polyp,26795,109,0.79 [0.52-1.21],0.2732993549850002
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27126,440,1.24 [1.01-1.53],0.0427303145647821
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Deviated nasal septum,26922,236,1.44 [1.09-1.91],0.0108943677722271
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16266,51,1.38 [0.74-2.56],0.3057909397083562
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25861,884,0.80 [0.69-0.93],0.0030888163368284
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Early onset COPD,27539,111,0.49 [0.32-0.74],0.0006404989298652
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27539,111,0.49 [0.32-0.74],0.0006404989298652
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",27539,111,0.49 [0.32-0.74],0.0006404989298652
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",26467,801,0.82 [0.70-0.96],0.0137295828668088
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Asthma,21624,801,0.83 [0.71-0.98],0.0246980476491414
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21479,801,0.84 [0.71-0.98],0.0274097177595088
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21608,785,0.83 [0.71-0.98],0.0253689298375376
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28067,58,0.33 [0.19-0.57],8.194979637589966e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Interstitial lung disease,26922,44,0.24 [0.13-0.45],8.922940506025794e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",28128,44,0.24 [0.13-0.45],7.585419541409079e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26915,37,0.23 [0.12-0.46],2.451744353430121e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pleural effusion,26900,79,0.64 [0.39-1.05],0.0796087650247642
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of pleura,27005,184,0.63 [0.46-0.87],0.0050568327849913
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27408,86,0.59 [0.37-0.95],0.0286120063970846
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19973,5187,1.04 [0.97-1.12],0.2904881552169647
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27634,501,0.91 [0.74-1.10],0.3307294904486484
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28191,142,1.62 [1.12-2.36],0.0110117120282122
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Impacted teeth,28197,132,1.60 [1.08-2.35],0.0180438679866054
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Dental caries,27256,123,0.68 [0.46-1.01],0.0563308796095636
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27242,109,0.88 [0.58-1.34],0.5577757692579108
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28175,157,1.51 [1.05-2.15],0.0241445631951588
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27228,95,0.89 [0.57-1.39],0.5980359963532091
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26968,64,0.58 [0.34-1.00],0.0520035956870768
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28133,45,0.67 [0.36-1.28],0.2252221780128184
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22714,202,0.89 [0.65-1.20],0.4367225597897213
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",24253,1741,1.14 [1.02-1.26],0.0207850533496543
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophagitis,22782,270,1.09 [0.84-1.42],0.5198024916724123
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23060,548,1.11 [0.92-1.34],0.2628249001340836
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22573,61,0.77 [0.44-1.34],0.3517953221891474
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22644,132,1.49 [1.03-2.15],0.0364578025571271
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22543,31,1.23 [0.56-2.69],0.601071507306615
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastric ulcer,22615,103,1.05 [0.69-1.60],0.8254458461813262
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Duodenal ulcer,22615,103,0.98 [0.64-1.49],0.9111323851808464
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28156,72,0.87 [0.53-1.45],0.6040225434090263
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Chronic gastritis,22613,101,0.87 [0.57-1.33],0.51884390974292
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23151,639,1.05 [0.88-1.25],0.5759137959389184
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of appendix,28067,165,0.77 [0.54-1.09],0.1405603809629717
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Functional dyspepsia,22898,386,1.38 [1.11-1.72],0.0036427919364012
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22627,115,1.34 [0.90-2.01],0.1539317675672032
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,28058,193,1.39 [1.03-1.89],0.0341892488343941
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute appendicitis,28031,129,0.70 [0.47-1.04],0.0777358857344485
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Hernia,25466,1181,0.87 [0.76-0.99],0.0296513615517664
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Inguinal hernia,24683,398,0.78 [0.63-0.98],0.0307236968222482
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Umbilical hernia,24404,119,0.70 [0.47-1.03],0.0733738406168457
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ventral hernia,24381,96,0.92 [0.60-1.43],0.7262452839366607
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24887,602,0.93 [0.78-1.11],0.4093132456168976
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27355,757,1.20 [1.03-1.41],0.021742526026549
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestines,23247,1696,1.14 [1.02-1.28],0.0174614696927268
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27919,72,1.56 [0.94-2.59],0.0869101806609154
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",28173,102,2.01 [1.32-3.05],0.0011004582701433
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn disease,26700,102,2.02 [1.33-3.08],0.0009648714790355
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26675,77,2.55 [1.60-4.07],7.887938927126274e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",28124,134,1.46 [1.00-2.11],0.0477155480837502
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcerative colitis,26732,134,1.47 [1.01-2.14],0.0428617566386981
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26715,117,1.44 [0.96-2.14],0.075918534581391
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27202,604,1.12 [0.94-1.34],0.2092126442818126
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27197,599,1.13 [0.94-1.35],0.1902478401545614
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21624,73,1.92 [1.17-3.15],0.009519418747872
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal stricture,27915,73,1.87 [1.14-3.05],0.0127499141518031
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21601,50,2.28 [1.27-4.10],0.005753180274484
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,21859,308,1.26 [0.98-1.61],0.0709901418248371
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21733,182,1.51 [1.09-2.08],0.0127592151784598
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21805,254,1.53 [1.17-2.01],0.0021676783396084
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Constipation,27069,228,1.45 [1.09-1.93],0.0104109971843413
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27825,82,1.17 [0.73-1.90],0.5149030321165667
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21733,182,1.42 [1.03-1.96],0.0305974298903048
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21642,91,0.79 [0.50-1.25],0.3187139533830065
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22351,800,1.01 [0.86-1.18],0.9250060185777444
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestine,21736,185,0.98 [0.72-1.35],0.923088618229742
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27812,69,1.18 [0.70-2.00],0.5284949242457279
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of liver,27506,123,1.55 [1.07-2.26],0.0220977837379495
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of liver,27449,66,1.12 [0.66-1.90],0.6673312294448658
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26997,528,1.10 [0.91-1.33],0.33401860443066
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholelithiasis,26883,414,1.13 [0.92-1.40],0.2470010373414484
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholecystitis,26549,80,0.90 [0.55-1.46],0.662146912773205
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26514,45,1.71 [0.91-3.22],0.0979454952963961
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute pancreatitis,26532,63,0.78 [0.46-1.34],0.3736168363764992
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),28084,63,0.77 [0.45-1.32],0.3438289125972924
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26965,285,0.82 [0.64-1.06],0.1382431623110707
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26748,68,0.58 [0.34-1.00],0.0487377496537922
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Coeliac disease,26733,53,0.45 [0.24-0.83],0.0100310954218064
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26721,41,1.36 [0.69-2.67],0.376610225281884
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26863,183,0.87 [0.63-1.20],0.3995860629758266
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,GI-bleeding,26858,178,0.84 [0.60-1.15],0.2740878703617061
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25613,1500,1.02 [0.91-1.15],0.7034004902637638
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27867,98,0.82 [0.53-1.26],0.3591719666832595
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27818,468,1.00 [0.82-1.23],0.9782566370925948
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27137,540,1.37 [1.14-1.65],0.0009079115318203
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27460,399,0.76 [0.61-0.95],0.016581100914102
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27167,106,0.51 [0.33-0.77],0.0014705253411668
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27287,226,0.96 [0.71-1.28],0.7565343456159284
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27996,85,0.66 [0.41-1.06],0.085788083927072
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27980,69,0.65 [0.39-1.10],0.1087368702869637
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27961,50,0.64 [0.35-1.17],0.1483274869318936
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28085,36,0.85 [0.41-1.77],0.662470649251546
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28082,33,0.83 [0.39-1.79],0.6339668358955381
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27414,64,0.90 [0.52-1.56],0.7113790550228474
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27707,357,0.99 [0.79-1.25],0.9604760656012834
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26667,70,1.02 [0.60-1.71],0.9501305287270854
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26696,99,1.74 [1.14-2.67],0.0108384796149539
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26680,83,1.48 [0.93-2.36],0.1015834393539145
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26812,215,1.25 [0.93-1.68],0.1339222238895508
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26784,187,1.21 [0.89-1.67],0.2273380954226871
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21864,3533,1.13 [1.04-1.22],0.0029610869184982
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,23504,1869,1.11 [1.00-1.23],0.0556260245245947
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25798,1111,1.19 [1.04-1.36],0.0102758329190118
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21752,117,1.22 [0.82-1.81],0.3225232450806535
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21972,337,1.33 [1.05-1.67],0.0174874233802975
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27920,111,1.05 [0.70-1.58],0.8094951654941511
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27937,100,1.25 [0.82-1.91],0.2937560124859787
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,22298,663,1.09 [0.92-1.29],0.326117800278463
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",24913,663,1.07 [0.90-1.27],0.4450351702700366
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21681,46,1.62 [0.88-2.98],0.1242680211232876
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27858,45,1.61 [0.87-3.00],0.1290628029237815
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,21784,149,1.43 [1.01-2.02],0.0420326955997906
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21660,25,1.16 [0.51-2.68],0.720242703203175
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,21759,124,0.82 [0.55-1.20],0.3033461402163141
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28146,62,0.91 [0.53-1.57],0.7326998942001339
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,21967,332,1.18 [0.93-1.50],0.1744033255610242
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21862,227,1.12 [0.84-1.49],0.4337215225306693
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,22884,1249,1.11 [0.98-1.27],0.0935369175773404
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21673,38,1.67 [0.84-3.33],0.1456607837344081
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21812,177,1.19 [0.86-1.65],0.2948345683329774
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21669,34,0.59 [0.28-1.25],0.167580347684915
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21666,31,0.65 [0.29-1.42],0.2794976644328596
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22159,524,1.03 [0.84-1.25],0.7971280203124455
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22071,436,1.06 [0.86-1.31],0.5934615730789496
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22356,282,1.17 [0.90-1.51],0.2403068703079148
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27858,154,1.18 [0.84-1.66],0.3369348702410356
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27745,41,1.42 [0.74-2.72],0.293732933845815
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25265,49,0.36 [0.20-0.68],0.0014080478250645
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25436,220,1.24 [0.93-1.65],0.1509830157176797
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26126,910,1.18 [1.02-1.36],0.0294220352704758
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25352,136,1.24 [0.86-1.79],0.2398211219211555
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25272,56,1.02 [0.57-1.80],0.956416922964184
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25980,764,1.21 [1.03-1.42],0.0182222460421311
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25275,59,1.25 [0.71-2.19],0.4456573717919796
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25470,254,0.97 [0.74-1.28],0.8345640665661458
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25329,113,0.78 [0.51-1.18],0.2391925609969863
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25285,69,1.16 [0.69-1.95],0.5849097886058697
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25362,146,1.14 [0.80-1.62],0.4801308148290695
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25283,67,1.08 [0.64-1.82],0.7861449078047922
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25543,327,1.36 [1.07-1.73],0.0111762250203712
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24973,286,1.24 [0.96-1.60],0.1010723992107246
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24743,56,1.35 [0.76-2.39],0.3109300066886885
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24740,53,1.11 [0.62-1.99],0.7351790782218388
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24803,116,1.23 [0.83-1.83],0.3073518405617096
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24742,55,0.97 [0.54-1.77],0.9263836214576407
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24752,65,0.50 [0.29-0.87],0.0138174017932155
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24736,49,0.54 [0.29-1.00],0.0515770999424047
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24922,235,1.37 [1.04-1.81],0.0260471005292916
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24739,52,1.51 [0.84-2.71],0.1666770103834802
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24742,55,0.94 [0.52-1.67],0.821078890382248
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24800,113,1.23 [0.82-1.84],0.3089791685840303
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24760,73,1.03 [0.62-1.72],0.8958446393845716
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25116,429,1.46 [1.19-1.80],0.00030370908037
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24831,144,1.57 [1.11-2.24],0.0113928292359411
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24909,222,1.43 [1.07-1.90],0.0143118007142861
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26861,100,1.11 [0.73-1.69],0.6287707532232709
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27104,343,1.37 [1.09-1.72],0.0079080940470915
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26819,58,1.44 [0.81-2.54],0.2112799303949639
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26829,68,1.20 [0.71-2.04],0.4957250248255335
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26877,116,1.57 [1.05-2.33],0.02643628875832
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23879,4424,1.39 [1.29-1.50],6.536580205131409e-19
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11459,417,1.34 [1.08-1.66],0.0080051877105759
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,26694,209,3.98 [3.01-5.26],3.1505848476707247e-22
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26540,55,1.67 [0.93-2.98],0.0835809674349877
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26848,43,2.64 [1.45-4.81],0.0015742321172521
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26854,49,,
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26858,53,5.97 [3.59-9.92],5.961941394936382e-12
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27874,245,1.11 [0.84-1.46],0.4694046340015883
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27946,53,2.31 [1.33-4.01],0.0029877306317803
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27800,171,1.24 [0.90-1.73],0.1894784306051155
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27725,96,0.77 [0.50-1.19],0.24333420026857
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26722,887,1.18 [1.02-1.37],0.0251196393291708
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Cystitis,25917,82,0.98 [0.61-1.59],0.950295547780804
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25900,65,1.25 [0.73-2.13],0.4179951992722178
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26017,182,1.14 [0.83-1.56],0.4210084213550517
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25924,89,1.18 [0.75-1.87],0.4700474291150356
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26459,624,1.30 [1.09-1.54],0.003586117163475
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11115,73,1.22 [0.74-2.01],0.4402877210478002
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11078,36,1.45 [0.72-2.91],0.2987187500288923
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hydrocele,11080,38,1.38 [0.70-2.72],0.3575525032392049
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11133,91,1.87 [1.20-2.92],0.0054612433716927
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11109,67,0.93 [0.54-1.61],0.8079537948964294
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11146,104,1.62 [1.07-2.46],0.0232430356378497
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15450,252,1.24 [0.94-1.64],0.1257232114554966
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15270,72,1.35 [0.81-2.25],0.2532173358222592
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,15288,90,1.37 [0.86-2.16],0.1836378363316374
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15253,55,1.24 [0.69-2.24],0.4671960456128361
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15412,392,1.07 [0.85-1.34],0.5722793673840425
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,15102,82,0.84 [0.51-1.37],0.4843864347435251
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15211,191,1.08 [0.78-1.49],0.6374298622368535
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,14207,2779,1.04 [0.95-1.14],0.3926459702783772
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Endometriosis,11725,297,0.88 [0.68-1.15],0.3467823211074671
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,11520,92,0.96 [0.60-1.53],0.8514981448954422
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11543,115,0.81 [0.54-1.24],0.3346819005050121
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11736,308,0.77 [0.59-0.99],0.0404587570453384
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11730,302,1.15 [0.89-1.49],0.2936092324525218
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11909,481,1.03 [0.84-1.27],0.7513989720676115
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11593,165,1.01 [0.71-1.42],0.973828413355832
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11648,220,1.13 [0.84-1.52],0.4304795974532112
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,11512,84,1.25 [0.76-2.06],0.3690030637919094
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,11569,141,0.96 [0.66-1.39],0.8223542489728091
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",15601,204,0.99 [0.72-1.34],0.9301912793938382
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,15611,195,0.96 [0.70-1.32],0.8195498062944281
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,15631,112,0.99 [0.65-1.50],0.9471357889839488
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",15622,122,1.02 [0.68-1.53],0.9056989850847356
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11501,73,1.54 [0.93-2.56],0.0960196803182523
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11486,58,0.78 [0.44-1.39],0.4009767987598917
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11504,76,0.80 [0.48-1.33],0.3900682540914081
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Irregular menses,15526,379,1.17 [0.93-1.47],0.1767424070395334
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",12578,1150,1.09 [0.95-1.24],0.2300120457859478
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Menorrhagia,12214,786,1.05 [0.89-1.24],0.5514236492167834
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",15610,155,1.31 [0.92-1.87],0.1315757530696513
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11782,354,1.14 [0.90-1.45],0.275784199039719
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11708,280,0.98 [0.75-1.28],0.8857818486062403
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11695,267,1.26 [0.96-1.65],0.0929688577653067
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Female infertility,11543,115,1.16 [0.75-1.79],0.4975410698506332
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",11536,108,1.06 [0.68-1.66],0.7938739725672028
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,15626,876,0.95 [0.80-1.13],0.5805924903750133
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,15631,1195,0.91 [0.78-1.06],0.219917348318734
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,15628,475,0.70 [0.57-0.87],0.0012711999474722
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,15290,137,0.59 [0.40-0.87],0.008489088441232
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,15340,187,0.88 [0.63-1.22],0.4335803047337864
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,15318,165,0.66 [0.47-0.94],0.0198638321116961
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",15644,166,0.82 [0.57-1.17],0.2755830359365296
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,15646,163,0.81 [0.56-1.16],0.2572350044146952
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,15643,414,1.06 [0.84-1.34],0.616122356149307
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,15351,122,1.24 [0.82-1.87],0.3097819280304706
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,15458,229,1.01 [0.74-1.37],0.956873066407095
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,14898,148,1.08 [0.73-1.59],0.7034548089018686
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,14950,200,0.80 [0.57-1.11],0.1738755011120786
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,14999,249,0.95 [0.70-1.28],0.7294321178943708
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,14899,149,0.90 [0.61-1.32],0.5803766719426023
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,14889,139,1.00 [0.67-1.49],0.999619278730756
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,14900,150,0.80 [0.55-1.17],0.2502635411222091
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,14668,232,0.82 [0.60-1.13],0.221546364648697
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],14871,435,0.98 [0.78-1.24],0.8771684991745383
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,15103,667,0.96 [0.79-1.17],0.6655860209643716
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",15648,166,0.84 [0.58-1.20],0.3302775203303469
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,14191,126,0.86 [0.57-1.31],0.4857167790306973
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",14537,101,0.76 [0.48-1.20],0.2348023756089435
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,15655,343,0.82 [0.64-1.06],0.1342484656832806
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,15575,263,0.77 [0.57-1.03],0.0739645279505679
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",15643,251,0.87 [0.65-1.17],0.3679717105901207
AGER,Advanced glycosylation end product-specific receptor,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",15633,241,0.87 [0.64-1.17],0.3532907741577874
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28012,37,0.82 [0.40-1.66],0.5819742915753627
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26589,528,0.86 [0.71-1.04],0.1271108736307331
